PAR 3.23% 30.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-1953

  1. 584 Posts.
    lightbulb Created with Sketch. 134
    Unsurprisingly the shorters have reloaded so the share price will continue to be grinded/suppressed like it has been for the last 12 months. I'm hopeful that PAR have realised that they have to stop conveying exact messaging so these leeches have some uncertainty.

    Best case scenario is that PAR follows through with only releasing to the market once they get an answer back from the FDA. Imagine if PAR "traps" the shorters late September with a trading halt and an announcement that the IND is open. One can only wish.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
30.0¢
Change
-0.010(3.23%)
Mkt cap ! $104.9M
Open High Low Value Volume
31.0¢ 31.5¢ 29.0¢ $161.3K 527.5K

Buyers (Bids)

No. Vol. Price($)
2 10756 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 62010 3
View Market Depth
Last trade - 16.10pm 15/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.